D-0271-2022 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0271-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Nov 12, 2021 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated Jun 23, 2023). Affected quantity: 2184 cartons.

Recall details

Product Type
Drugs
Report Date
Dec 15, 2021
Initiation Date
Nov 12, 2021
Termination Date
Jun 23, 2023
Product Quantity
2184 cartons

Product description

Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy & Congestion, 12 Hour, 30 Tablets, Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152, www.rugbylaboratories.com. NDC 0638-1242-07.

Reason for recall

Failed dissolution specifications

Distribution pattern

USA Nationwide.

Code information

Lot #: AC2103329D, Exp 1/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0271-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0271-2022. Report a data issue: hello@regdatalab.com.